Allergy Asthma Clin Immunol. 2015 Jan 27;11(1):5. doi: 10.1186/s13223-015-0071-3. eCollection 2015.
Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Anne K Ellis, Lisa M Steacy, Barnaby Hobsbawn, Caroline E Conway, Terry Jb Walker
Affiliations
Affiliations
- Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, ON Canada ; Allergy Research Unit, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2 V7 Canada.
- Allergy Research Unit, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2 V7 Canada.
PMID: 25653682
PMCID: PMC4316395 DOI: 10.1186/s13223-015-0071-3
Abstract
RATIONALE: The Environmental Exposure Unit (EEU), a controlled allergen exposure model of allergic rhinitis (AR), has traditionally utilized ragweed pollen. We sought to clinically validate the use of grass pollen in the EEU.
METHODS: Healthy volunteers with a history of AR symptoms during grass pollen season and supportive skin test responses attended the EEU for 3 hrs of rye grass pollen exposure (Lolium Perenne). Non-atopic controls were also recruited. Participants assessed individual rhinoconjunctivitis symptoms to generate Total Nasal Symptom Score (TNSS; max 12) and Total Symptom Score (TSS; max 24) and recorded Peak Nasal Inspiratory Flow (PNIF) q30min while in the EEU. Participants returned the following day for an additional 3 hrs of pollen exposure. Two separate groups allowed for the exploration of lower vs. higher pollen concentrations and subsequent effects on symptoms.
RESULTS: 78 participants were screened, of whom 39 were eligible and attended the 2x3h EEU visits, plus 8 non-atopic controls. Mean TSS, TNSS and PNIF values amongst participants in the higher pollen concentration group (target 3500 grains/m3) after the first 3 hr exposure were 18.9, 9.7 and 68 L/min, respectively. In comparison, mean TSS, TNSS and PNIF values in the lower pollen concentration (2500 grains/m3) group were only 13.3, 7.6, and 82 L/min, respectively. The subsequent day of pollen exposure did not appreciably alter the maximal TSS/TNSSs, but rather resulted in a more rapid onset of symptomatology, with higher mean scores at the 30 min, 60 min and 90 min timepoints. The non-atopic controls remained asymptomatic.
CONCLUSIONS: This study provides clinical validation of the ability to generate allergic rhinoconjunctivitis symptoms amongst grass-allergic individuals in the EEU.
Keywords: Allergic rhinitis; Controlled allergen challenge; Environmental exposure unit; Grass pollen
References
- Ann Allergy Asthma Immunol. 2006 Feb;96(2):263-77; quiz 277-8, 315 - PubMed
- Allergy Asthma Clin Immunol. 2013 May 01;9(1):16 - PubMed
- Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33 - PubMed
- Allergy Asthma Proc. 2005 Jul-Aug;26(4):275-82 - PubMed
- Ann Allergy Asthma Immunol. 1997 Dec;79(6):533-40 - PubMed
- Ann Allergy Asthma Immunol. 2013 Nov;111(5):323-8 - PubMed
- Ann Allergy Asthma Immunol. 2010 Apr;104(4):293-8 - PubMed
- Ann Allergy Asthma Immunol. 1997 Aug;79(2):163-72 - PubMed
- J Allergy Clin Immunol. 2000 Mar;105(3):489-94 - PubMed
- Ann Allergy Asthma Immunol. 2001 Apr;86(4):393-6 - PubMed
- Allergy Asthma Proc. 2009 May-Jun;30(3):270-6 - PubMed
- Ann Allergy Asthma Immunol. 1999 Aug;83(2):83-9; quiz 89-93 - PubMed
- Ann Allergy Asthma Immunol. 1999 Jul;83(1):33-9 - PubMed
- Ann Allergy Asthma Immunol. 2003 Oct;91(4):375-85 - PubMed
- Ann Allergy Asthma Immunol. 2015 Apr;114(4):344-5 - PubMed
Publication Types